stockrowCardio Diagnostics Holdings, Inc. (CDIO) vs Cerenome, Inc. (CNSY)
- Cardio Diagnostics Holdings, Inc. CDIO 1.65 −1.79%
- Cerenome, Inc. CNSY 0.64 −4.48%
Cardio Diagnostics Holdings, Inc. and Cerenome, Inc. are both Biotechnology companies. Cardio Diagnostics Holdings, Inc. and Cerenome, Inc. are of similar size ($5.1M and $5.0M). Cardio Diagnostics Holdings, Inc. grew revenue faster over the last twelve months: −3.23% against −21.0%. Cerenome, Inc. has the higher net margin (−620.7% vs −42,429.2%) and the lower return on invested capital (−532.8% vs −228.0%). Across the 15 metrics below, Cerenome, Inc. leads on 8 and Cardio Diagnostics Holdings, Inc. on 7.
Valuation
Profitability
| Metric | CDIO | CNSY | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 68.51% |
| Operating margin | (42,356.17%) | (628.12%) | 0.00% |
| Net margin | (42,429.24%) | (620.70%) | 0.00% |
| Free cash flow margin | (37,817.51%) | (560.29%) | 0.00% |
| Return on equity | (93.55%) | (614.05%) | (51.96%) |
| Return on assets | (87.24%) | (214.01%) | (46.06%) |
| Return on invested capital | (227.98%) | (532.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack